Evidence map›Paper›PMID 41557223›Full record

ArticleArchives of microbiology2026

1,2,4-triazole-3-one Schiff bases disrupt cell membrane integrity of both Gram-positive and -negative bacteria.

Bengü Ergüden, Yasemin Ünver

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bengü ErgüdenDepartment of Bioengineering, Gebze Technical University, Kocaeli, 41400, Turkey. b.sezen@gtu.edu.tr.
Yasemin ÜnverDepartment of ChemistryFaculty of Sciences, Karadeniz Technical University, Trabzon, 61080, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triazoles have significant antibacterial and antifungal properties that protect against dangerous fungus, bacteria, pathogens, and even antibiotic-resistant microbes that lead to infectious disorders and food degradation. Although they are known to target a number of essential metabolic pathways in bacterial cells, very little is known about how they affect the integrity of the cell membrane. In the current investigation, we compared the antibacterial activity of various distinct substituted 1,2,4-triazole-3-one Schiff base derivatives and found that bis-1,2,4-triazole-3-one Schiff bases have higher antibacterial activity against both Gram-positive and Gram-negative bacteria than 1,2,4-triazole-3-one Schiff bases. We further show that these compounds enhance ionic cell membrane permeability more than the other substituted components, and that the cell membrane is the first barrier that these molecules encounter during their action. Ion leakage is particularly detectable within minutes as the bacteria cells are treated with the minimum inhibitory concentration amounts of the compounds. The antibacterial activity of bis-1,2,4-triazole-3-one Schiff bases is superior to that of other substituted derivatives, and ions detectable by the conductivity measurements leak out from the bacteria. The loss of cell membrane integrity is also demonstrated by the propidium iodide uptake experiments. Therefore, we suggest that the disruption of the cell membrane integrity and ion leakage plays a role in the higher activity of triazole compounds against both Gram-negative and -positive bacteria.

Indexed as

Anti-Bacterial AgentsCell MembraneGram-Negative BacteriaGram-Positive BacteriaTriazolesCell Membrane PermeabilityMicrobial Sensitivity TestsSchiff Bases1,2,4-triazoleAnti-Bacterial AgentsSchiff BasesTriazoles1,2,4-triazole-3-oneAntibacterial activityBacillus subtilisCell membraneEscherichia coliGram-negative bacteriaGram-positive bacteriaPseudomonas aeruginosaSchiff baseStaphylococcus aureus

Identifiers

PMID41557223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.